Scope for meaningful rate cuts going ahead Neelkanth Mishra SK bioscience and VECOL Forge Partnership for Vaccine Manufacturing in Colombia Novartis Raises FullYear Sales and Profit Outlook Signaling Strong Operating Momentum Dow Jones Futures Edge Higher as SP 500 and Nasdaq Record Fresh Highs AI Sector Draws Investor Attention Delivery Robots Flooding LA Streets Raise Pedestrian Safety Concerns HF Sinclair Corp Subject of New Analyst Report from Yahoo Finance ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development RHP Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise but Stock Slips 08 ACNB Corporation ACNB Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Lower GWW Q1 2026 Earnings EPS Exceeds Estimates by Nearly 13 Despite Slight Stock Decline VEON Q1 2026 Earnings Earnings Beat Expectations Despite Lack of Revenue Disclosure KKRT Q1 2026 Earnings Strong EPS Surprise of 657 Signals Underlying Strength for KKR Subordinated Notes Gabelli Healthcare Wellness Trust GRX Edges Higher Amid Steady Trading Green Brick Partners Holds Near Support Amid Modest Decline Bloom Energy BE Faces Selling Pressure as Stock Retreats from Resistance Zone Daedalus Special Acquisition Corp Warrants DSACW Remain Flat at 045 as Market Awaits Catalysts DigitalOcean Plunges 6 Support Levels in Focus as Cloud Sector Headwinds Intensify SP 500 Edges Higher as Healthcare and Tech Rally Communication Services Lags TELO Q4 2025 Earnings WiderthanExpected Loss Stings as PreRevenue Biotech Focuses on Pipeline CRISPR Therapeutics CRSP Holds Near Support as Biotech Sector Awaits Catalysts Marathon Bancorp Inc MBBC Posts Strong Gains Approaches Resistance Level Quantum Corporation QMCO Retreats 32 as Stock Tests Key Support Levels Smart Sand Inc SND Holds Steady Near Support as Energy Sector Shows Mixed Signals Blue Water Acquisition Corp III Warrants BLUWW Decline Further Testing Key Support Levels RLX Technology Slides 419 as Bears Test Key Support Near 200 Praetorian Acquisition Corp PTOR Holds Steady Near Support Amid Muted Activity Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny